Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-24

Clinical Trial Update: Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

View source ↗

Summary

This clinical trial update reports on PegIntron (pegylated interferon alfa-2b) as monotherapy or in combination with ribavirin for chronic hepatitis C, study P0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PegIntron (pegylated interferon alfa-2b)
  • Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepacivirus | Status: COMPLETED | Results posted: 2010-06-24